Approval · Notice of Compliance 394 · 2002
REACTINE ALLERGY & SINUS: Notice of Compliance 394
Issued September 30, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 394
- Date
- September 30, 2002
- Company
- Pfizer Canada Inc., Consumer Healthcare DivisionMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Histamine h1 receptor antagonist, sympathomimetic amine
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REACTINE ALLERGY & SINUS | 02246162 | Marketed |
Medicinal ingredients
- CETIRIZINE HYDROCHLORIDE 5 MG per TAB
- PSEUDOEPHEDRINE HCL 120 MG per TAB